Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries

Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Liver international 2023-08, Vol.43 (8), p.1842-1843
1. Verfasser: Razavi, Homie
Format: Artikel
Sprache:eng
Schlagworte:
Antiviral Agents - therapeutic use
Developing Countries
Global Health
Hepatitis
Hepatitis, Viral, Human - drug therapy
Hepatitis, Viral, Human - epidemiology
Hepatitis, Viral, Human - prevention & control
Humans
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1843
container_issue 8
container_start_page 1842
container_title Liver international
container_volume 43
creator Razavi, Homie
description
doi_str_mv 10.1111/liv.15636
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829431269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829431269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-38c98b1fced126ceb23378f6bbb80f72076c968a2eb5033853ce35ac0ec05d393</originalsourceid><addsrcrecordid>eNp1kc1KJDEURsOgqKMu5gUk4GZm0ZrkWqnUUmR-hIYBUbdFKnWrO5JK2qSqm975CD7jPMmkux0XA2aTXL7D4ZKPkC-cXfB8Lp1dXvBCgvxEjvhVqSYggO-9vwUcks8pPTHGq6rgB-QQSigYU_KIuDtMi-AT0iHQsMRoQm_9jA5zpGaunUM_w0Stp-hsTvSwSZc2akfnuMjjYLexC6s_L69U-5b2tm0d5sn6bMueMPohWkwnZL_TLuHp231MHn58v7_5NZn-_nl7cz2dGChATkCZSjW8M9hyIQ02AqBUnWyaRrGuFKyUppJKC2wKBqAKMAiFNgwNK1qo4Jh83XkXMTyPmIa6t8mgc9pjGFMtlKiuILs36Pl_6FMYo8_bZQpKAUIxmalvO8rEkFLErl5E2-u4rjmrNxXUuYJ6W0Fmz96MY9Nj-07--_MMXO6AlXW4_thUT28fd8q_DbuS0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2837232806</pqid></control><display><type>article</type><title>Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Razavi, Homie</creator><creatorcontrib>Razavi, Homie</creatorcontrib><identifier>ISSN: 1478-3223</identifier><identifier>EISSN: 1478-3231</identifier><identifier>DOI: 10.1111/liv.15636</identifier><identifier>PMID: 37350086</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Antiviral Agents - therapeutic use ; Developing Countries ; Global Health ; Hepatitis ; Hepatitis, Viral, Human - drug therapy ; Hepatitis, Viral, Human - epidemiology ; Hepatitis, Viral, Human - prevention &amp; control ; Humans</subject><ispartof>Liver international, 2023-08, Vol.43 (8), p.1842-1843</ispartof><rights>2023 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>2023 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-38c98b1fced126ceb23378f6bbb80f72076c968a2eb5033853ce35ac0ec05d393</citedby><cites>FETCH-LOGICAL-c3536-38c98b1fced126ceb23378f6bbb80f72076c968a2eb5033853ce35ac0ec05d393</cites><orcidid>0000-0002-2658-6930</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fliv.15636$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fliv.15636$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37350086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Razavi, Homie</creatorcontrib><title>Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries</title><title>Liver international</title><addtitle>Liver Int</addtitle><subject>Antiviral Agents - therapeutic use</subject><subject>Developing Countries</subject><subject>Global Health</subject><subject>Hepatitis</subject><subject>Hepatitis, Viral, Human - drug therapy</subject><subject>Hepatitis, Viral, Human - epidemiology</subject><subject>Hepatitis, Viral, Human - prevention &amp; control</subject><subject>Humans</subject><issn>1478-3223</issn><issn>1478-3231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1KJDEURsOgqKMu5gUk4GZm0ZrkWqnUUmR-hIYBUbdFKnWrO5JK2qSqm975CD7jPMmkux0XA2aTXL7D4ZKPkC-cXfB8Lp1dXvBCgvxEjvhVqSYggO-9vwUcks8pPTHGq6rgB-QQSigYU_KIuDtMi-AT0iHQsMRoQm_9jA5zpGaunUM_w0Stp-hsTvSwSZc2akfnuMjjYLexC6s_L69U-5b2tm0d5sn6bMueMPohWkwnZL_TLuHp231MHn58v7_5NZn-_nl7cz2dGChATkCZSjW8M9hyIQ02AqBUnWyaRrGuFKyUppJKC2wKBqAKMAiFNgwNK1qo4Jh83XkXMTyPmIa6t8mgc9pjGFMtlKiuILs36Pl_6FMYo8_bZQpKAUIxmalvO8rEkFLErl5E2-u4rjmrNxXUuYJ6W0Fmz96MY9Nj-07--_MMXO6AlXW4_thUT28fd8q_DbuS0w</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Razavi, Homie</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2658-6930</orcidid></search><sort><creationdate>202308</creationdate><title>Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries</title><author>Razavi, Homie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-38c98b1fced126ceb23378f6bbb80f72076c968a2eb5033853ce35ac0ec05d393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>Developing Countries</topic><topic>Global Health</topic><topic>Hepatitis</topic><topic>Hepatitis, Viral, Human - drug therapy</topic><topic>Hepatitis, Viral, Human - epidemiology</topic><topic>Hepatitis, Viral, Human - prevention &amp; control</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Razavi, Homie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Liver international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Razavi, Homie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries</atitle><jtitle>Liver international</jtitle><addtitle>Liver Int</addtitle><date>2023-08</date><risdate>2023</risdate><volume>43</volume><issue>8</issue><spage>1842</spage><epage>1843</epage><pages>1842-1843</pages><issn>1478-3223</issn><eissn>1478-3231</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37350086</pmid><doi>10.1111/liv.15636</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-2658-6930</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1478-3223
ispartof Liver international, 2023-08, Vol.43 (8), p.1842-1843
issn 1478-3223
1478-3231
language eng
recordid cdi_proquest_miscellaneous_2829431269
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antiviral Agents - therapeutic use
Developing Countries
Global Health
Hepatitis
Hepatitis, Viral, Human - drug therapy
Hepatitis, Viral, Human - epidemiology
Hepatitis, Viral, Human - prevention & control
Humans
title Response to overcoming the challenges in eliminating viral hepatitis in low‐ and middle‐income countries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A11%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20overcoming%20the%20challenges%20in%20eliminating%20viral%20hepatitis%20in%20low%E2%80%90%20and%20middle%E2%80%90income%20countries&rft.jtitle=Liver%20international&rft.au=Razavi,%20Homie&rft.date=2023-08&rft.volume=43&rft.issue=8&rft.spage=1842&rft.epage=1843&rft.pages=1842-1843&rft.issn=1478-3223&rft.eissn=1478-3231&rft_id=info:doi/10.1111/liv.15636&rft_dat=%3Cproquest_cross%3E2829431269%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2837232806&rft_id=info:pmid/37350086&rfr_iscdi=true